Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
358.00    2.00 (0.56%)
Bid:
354.00
Ask:
356.50
Spread: 2.50 (0.706%)
Market Cap: £1.83b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

2023 AGM results update statement

19 Jan 2024 16:30

RNS Number : 3461A
Caledonia Investments PLC
19 January 2024

Caledonia Investments plc

2023 annual general meeting ("AGM") results update statement

In accordance with Provision 4 of the UK Corporate Governance Code, Caledonia Investments plc (the "Company") provides an update on the feedback received and any actions the Company intends to take following the outcome of voting in respect of resolution 19 at the 2023 AGM.

Resolution 19 was the waiver of the mandatory offer provisions set out in Rule 9 of The City Code on Takeovers and Mergers in relation to the Cayzer family concert party, given the obligation that could arise on the concert party to make a general offer for the entire issued share capital of the Company as a result of purchases by the Company of ordinary shares pursuant to the authority received from shareholders to make market purchases.

Resolution 19 passed with a majority of votes cast by independent shareholders in favour. However, more than 20% of participating independent shareholders voted against. This included one large shareholder who, having previously supported the resolution, recently adopted a policy of voting in line with the voting recommendations of a proxy voting advisor which is generally not supportive of such Rule 9 waiver resolutions given their potential to lead to creeping control. In response to the feedback received from this shareholder, who continues to be supportive of management, the Company continues to engage with this proxy voting advisor.

The Company is grateful to all those that have taken the time to engage on this issue. We recognise the concern raised by the proxy voting advisor. However, the directors believe that the Company's ability to exercise the authority to make market purchases of its own shares warranted approval of the Rule 9 waiver resolution.

19 January 2024

For further information please contact:

Company contacts

Caledonia Investments plc

+44 20 7802 8080

David Stewart

Chairman

Media contacts

Teneo

+44 20 7353 4200

Tom Murray

Robert Yates

caledonia@teneo.com

END

Notes for editors:

Caledonia Investments plc

Caledonia is a self-managed investment trust company. Our aim is to grow net assets and dividends paid to shareholders, whilst managing risk to avoid the permanent loss of capital. We achieve this by investing in proven, well-managed businesses that combine long term growth characteristics with an ability to deliver increasing levels of income. We hold investments in both listed and private markets, covering a range of sectors and, particularly through the listed and fund investments, have a global reach.

For additional information on Caledonia, please visit www.caledonia.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
AGMSFSFLUELSEIF
Date   Source Headline
4th Oct 20181:57 pmRNSNet Asset Value(s)
6th Sep 20189:41 amRNSNet Asset Value(s)
1st Aug 20181:43 pmRNSPortfolio Update
19th Jul 201812:52 pmRNSResult of AGM
16th Jul 201811:28 amRNSDirectorate Change
13th Jul 20187:49 amRNSAcquisition
6th Jul 201810:34 amRNSReport for the quarter ended 30 June 2018
6th Jul 201810:31 amRNSNet Asset Value(s)
2nd Jul 20188:35 amRNSBlock listing Interim Review
28th Jun 201811:34 amRNSHolding(s) in Company
19th Jun 20189:12 amRNSAnnual Financial Report
6th Jun 201812:47 pmRNSNet Asset Value(s)
31st May 20185:11 pmRNSTotal Voting Rights
31st May 20183:00 pmRNSDirector/PDMR Shareholding
31st May 20189:17 amRNSDirector/PDMR Shareholding
25th May 20185:02 pmRNSTransaction in Own Shares
24th May 20185:11 pmRNSFinal Results - Correction
24th May 20187:00 amRNSFinal Results
4th May 201810:31 amRNSNet Asset Value(s)
13th Apr 20184:31 pmRNSHolding(s) in Company
9th Apr 201811:51 amRNSNet Asset Value(s)
29th Mar 20183:33 pmRNSTransaction in Own Shares
6th Mar 201810:03 amRNSNet Asset Value(s)
15th Feb 20183:14 pmRNSDirector/PDMR Shareholding
6th Feb 20181:14 pmRNSNet Asset Value(s)
8th Jan 201812:31 pmRNSDirector/PDMR Shareholding
5th Jan 20181:24 pmRNSReport for the quarter ended 31 Dec 2017
5th Jan 20181:19 pmRNSNet Asset Value(s)
2nd Jan 20189:49 amRNSBlock listing Interim Review
20th Dec 201710:44 amRNSDirector/PDMR Shareholding
12th Dec 20178:57 amRNSHalf-year Report
6th Dec 201712:20 pmRNSNet Asset Value(s)
30th Nov 20175:29 pmRNSDirector/PDMR Shareholding
30th Nov 201711:39 amRNSDirectorate Change
23rd Nov 20177:00 amRNSHalf-year Report
6th Nov 20173:23 pmRNSNet Asset Value(s)
1st Nov 20179:24 amRNSHolding(s) in Company
30th Oct 20174:08 pmRNSDisposal
6th Oct 201711:33 amRNSNet Asset Value(s)
5th Oct 20178:45 amRNSHolding(s) in Company
3rd Oct 20179:21 amRNSHolding(s) in Company
29th Sep 201711:21 amRNSHolding(s) in Company
8th Sep 20178:48 amRNSDirectorate Change
6th Sep 20178:53 amRNSNet Asset Value(s)
21st Aug 20179:50 amRNSChange of Registered Office
18th Aug 20179:59 amRNSHolding(s) in Company
4th Aug 20173:46 pmRNSNet Asset Value(s)
24th Jul 20175:09 pmRNSDirector/PDMR Shareholding
20th Jul 20173:28 pmRNSResult of AGM
6th Jul 20173:11 pmRNSReport for quarter ended 30 June 2017

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.